EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies

Quirin Hammer, Karlo Perica, Rina M Mbofung, Hanna van Ooijen, Karen E Martin, Pouria Momayyezi, Erika Varady, Yijia Pan, Mark Jelcic, Brian Groff, Ramzey Abujarour, Silje Z Krokeide und 7 weitere

Cell Stem Cell · 2024-09 · 31 (9) · 1376-1386.e8

DOI: 10.1016/j.stem.2024.06.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2024-09. Verfasst von Quirin Hammer und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: quirin.hammer@ki.se. Hauptthemen laut MEDLINE: Killer Cells, Natural. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalAnimalsMiceLigandsInduced Pluripotent Stem CellsMice, Inbred C57BLGraft RejectionImmunotherapyCD58 AntigensHumansbeta 2-MicroglobulinReceptors, Chimeric AntigenIntercellular Adhesion Molecule-1

Stichwörter der Autor:innen

CAR T cellsCD54CD58allogeneic cell therapyhyopimmuneiPSC-derived NK cellsimmune evasionimmune synapsenatural killer cells

Substanzen

LigandsCD58 Antigensbeta 2-MicroglobulinReceptors, Chimeric AntigenIntercellular Adhesion Molecule-1

Autor:innen und Institutionen

  • Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. Electronic address: quirin.hammer@ki.se.
  • Department of Medicine, Weill Cornell Medical College, New York, NY, USA; Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Cell Therapy Service, Department of Medicine, Memorial Sl…
  • Fate Therapeutics, Inc., San Diego, CA, USA.
  • Department of Applied Physics, Science for Life Laboratory, KTH Royal Institute of Technology, Solna, Sweden.
  • Precision Immunotherapy Alliance, Institute for Cancer Research, University of Oslo, Oslo, Norway; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.

Förderung

  • NCI NIH HHS

Zitieren

APA

Hammer, Q., Perica, K., Mbofung, R. M., van Ooijen, H., Martin, K. E., Momayyezi, P., Varady, E., Pan, Y., Jelcic, M., Groff, B., Abujarour, R., Krokeide, S. Z., Lee, T., Williams, A., Goodridge, J. P., Valamehr, B., Önfelt, B., Sadelain, M., & Malmberg, K. J. (2024). Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. Cell Stem Cell, 31(9), 1376-1386.e8. https://doi.org/10.1016/j.stem.2024.06.011

Vancouver

Hammer Q, Perica K, Mbofung RM, van Ooijen H, Martin KE, Momayyezi P, et al. Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. Cell Stem Cell. 2024;31(9):1376-1386.e8. doi:10.1016/j.stem.2024.06.011

BibTeX
@article{Hammer2024,
  author = {Hammer, Quirin and Perica, Karlo and Mbofung, Rina M and van Ooijen, Hanna and Martin, Karen E and Momayyezi, Pouria and Varady, Erika and Pan, Yijia and Jelcic, Mark and Groff, Brian and Abujarour, Ramzey and Krokeide, Silje Z and Lee, Tom and Williams, Alan and Goodridge, Jode P and Valamehr, Bahram and Önfelt, Björn and Sadelain, Michel and Malmberg, Karl-Johan},
  title = {Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies},
  journal = {Cell Stem Cell},
  year = {2024},
  volume = {31},
  number = {9},
  pages = {1376--1386.e8},
  doi = {10.1016/j.stem.2024.06.011}
}
Kostenlos starten →